ProCE Banner Activity

Diagnosing CDI: Differentiating Between Stool Assays

Clinical Thought

Detection of C. difficile infection remains a challenge. Read my commentary on the different stool assays available, including testing limitations, and my approach to diagnosing CDI.

Released: March 29, 2023



Paul Feuerstadt

Paul Feuerstadt, MD, FACG, AGAF

Assistant Clinical Professor of Medicine
Attending Gastroenterologist
Department of Gastroenterology
Yale University School of Medicine
PACT-Gastroenterology Center
Hamden, Connecticut

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


This activity is supported by an educational grant from

Merck Sharp & Dohme Corp.


Peggy Lillis Foundation

ProCE Banner


Paul Feuerstadt, MD, FACG, AGAF: consultant/advisor/speaker: Ferring/Rebiotix, Merck, SERES Therapeutics, Summit Therapeutics.